A Phase 2/3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy, Safety and Tolerability of BHV 7000 in Subjects with Refractory Focal Onset Epilepsy

Project: Research

Project Details

StatusActive
Effective start/end date10/12/24 → 10/12/26

Keywords

  • clinical trial
  • epilepsy
  • refractory disease

Clinical Trial Phase

  • Phase II
  • Phase III (a & b)